Atopic dermatitis (AD) is one of the most common inflammatory skin diseases affecting
children and adults. The intense pruritus and rash can be debilitating, significantly impairing …

Atopic dermatitis is the most prevalent chronic inflammatory skin condition globally. The
burden of atopic dermatitis on children and adults is extensive and there is also significant …

Background Baricitinib, an oral selective Janus kinase 1/Janus kinase 2 inhibitor, is being
studied for moderate-to-severe atopic dermatitis (AD) in adults. Objective To evaluate the …

Importance Measuring outcomes in clinical practice can aid patient care, quality
improvement, and real-world evidence generation. The Harmonising Outcome Measures for …

Dupilumab is an anti-interleukin-4 receptor monoclonal antibody that was recently approved
for the treatment of atopic dermatitis (AD). In this single-center retrospective study, clinical …

Psychodermatology is a subspecialty of dermatology that is of increasing interest to
dermatologists and patients. The case for the provision of at least regional …

Background Atopic dermatitis (AD) is associated with eczematous lesions, pruritus, pain,
and sleep disturbance, which may negatively impact mental health over time. Objective To …

Background Multiple strategies have been used to evaluate the minimal important change
(MIC) of the Eczema Area and Severity Index (EASI) and Scoring Atopic Dermatitis …

Background Atopic dermatitis (AD) is associated with itch, pain, and sleep disturbance, all of
which may contribute toward cognitive dysfunction. Objective To determine the relationship …

Atopic dermatitis (AD) is characterized by a heterogenous longitudinal course with varying
severity, flares, and persistence. However, AD course is not routinely assessed in clinical …